Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
RESEARCH TOOLSreports
Fresenius Medical Care AG & Co. KGaA (FME) Stock Price & Analysis
9 Followers
FME Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€30.16 - €49.62
Previous Close€39.26
Volume119.80K
Average Volume (3M)454.61K
Market Cap
€11.52B
Enterprise Value€19.07B
Total Cash (Recent Filing)€1.56B
Total Debt (Recent Filing)€7.90B
Price to Earnings (P/E)23.1
Beta0.65
Next Earnings
May 07, 2024EPS Estimate
€0.55Next Dividend Ex-DateN/A
Dividend Yield2.85%
Share Statistics
EPS (TTM)1.70
Shares Outstanding293,413,449
10 Day Avg. Volume566,298
30 Day Avg. Volume454,610
Standard Deviation0.09
R-Squared0.15
Alpha-0.00694
Financial Highlights & Ratios
Price to Book (P/B)-2.87
Price to Sales (P/S)0.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€36.85Price Target Upside-7.34% Downside
Rating ConsensusHold
Number of Analyst Covering12
Fresenius Medical Care AG & Co. KGaA News
Bulls Say, Bears Say
Bulls Say
Contractual AdjustmentsCare Enablement now includes indexation clauses in its new contracts to ensure inflation and deflation are passed through.
Earnings PerformanceQ4 earnings came slightly above expectations, aided by the one-off Tricare Settlement benefits in Care Delivery.
Financial GoalsManagement reiterated their ambition to reach 8-12% by 2025.
Bears Say
Company StrategyAfter closing 72 clinics in 2023, Fresenius Medical Care could be closing only a single digit number of clinics in 2024, limiting profitability gains from higher utilisation rates.
Financial PerformanceLimited visibility on the turnaround, continuous FX headwinds, and muted patient volume growth challenge profitability targets.
ValuationValuation remains expensive with the company trading at about 13x P/E 2024, and expected sales CAGR significantly lagging behind the sector.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
20.00% Mutual Funds
5.57% Other Institutional Investors
74.43% Public Companies and
Individual Investors
FME FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest stock price was €30.16 and its highest was €49.62 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Currently, no data Available
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is May 07, 2024 which is 2 days ago.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Feb 20, 2024. The company reported €0.88 earnings per share for the quarter, beating the consensus estimate of €0.834 by €0.046.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Overvalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA does not currently pay dividends.
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is €0.55.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.88 in its last earnings report, beating expectations of €0.834. Following the earnings report the stock price went down -4.46%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:FME
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€36.85 (-7.34% Downside)
€36.85 (-7.34% Downside)
Insider Transactions
Bought Shares
Worth €977.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.45%
12-Months-Change
Fundamentals
Return on Equity
3.62%
Trailing 12-Months
Asset Growth
-5.10%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
FME Stock 12 Month Forecast
Average Price Target
€36.85
▼(-7.34% Downside)
Technical Analysis
Best Analysts Covering FME
1 Year
1 Year Success Rate
17/30 ratings generated profit
1 Year Average Return
+0.47%
reiterated a sell rating 13 days ago
Copying James Vane's trades and holding each position for 1 Year would result in 56.67% of your transactions generating a profit, with an average return of +0.47% per trade.
---